| dc.contributor | Vall d'Hebron Barcelona Hospital Campus |
| dc.contributor.author | Lazarus, Jeffrey V. |
| dc.contributor.author | Miralles-Sanchez, Juan Emilio |
| dc.contributor.author | Agirre Garrido, Leire |
| dc.contributor.author | Brachowicz, Nicolai |
| dc.contributor.author | Nicolàs Olivé, Aina |
| dc.contributor.author | Armenta, Anthony |
| dc.contributor.author | Pericas, Juan M |
| dc.date.accessioned | 2025-04-29T11:13:20Z |
| dc.date.available | 2025-04-29T11:13:20Z |
| dc.date.issued | 2025-05 |
| dc.identifier.citation | Lazarus JV, Miralles-Sanchez JE, Agirre-Garrido L, Brachowicz N, Nicolàs A, Anthony JR, et al. A call to action to address the steatotic liver disease public health threat in Barcelona. Lancet Reg Heal - Eur. 2025 May;52:101272. |
| dc.identifier.issn | 2666-7762 |
| dc.identifier.uri | http://hdl.handle.net/11351/13010 |
| dc.description | City health; Health policy; Liver disease |
| dc.description.abstract | Despite their high prevalence worldwide, steatotic liver diseases (SLDs) are largely excluded from most non-communicable disease (NCD) guidelines and strategies. We propose policies and strategies to achieve the United Nations Sustainable Development Goal of reducing NCD premature mortality by one-third by 2030. To assess this gap—the exclusion of SLDs from NCD policies—in urban areas, we reviewed Barcelona’s strategies for NCD risks (e.g., alcohol, tobacco, healthy food access). We then explored applications of geo-spatial visualisation and whole-of-society approaches (e.g., citizen science engagement) aligned with the World Health Organization (WHO) Best Buys to provide recommendations to address NCDs, generally, and SLDs specifically. |
| dc.language.iso | eng |
| dc.publisher | Elsevier |
| dc.relation.ispartofseries | The Lancet Regional Health - Europe;52 |
| dc.rights | Attribution-NonCommercial-NoDerivatives 4.0 International |
| dc.rights.uri | http://creativecommons.org/licenses/by-nc-nd/4.0/ |
| dc.source | Scientia |
| dc.subject | Salut urbana |
| dc.subject | Política sanitària |
| dc.subject | Fetge - Malalties - Tractament |
| dc.subject.mesh | Liver Diseases |
| dc.subject.mesh | /therapy |
| dc.subject.mesh | Health Policy |
| dc.subject.mesh | Urban Health |
| dc.title | A call to action to address the steatotic liver disease public health threat in Barcelona |
| dc.type | info:eu-repo/semantics/article |
| dc.identifier.doi | 10.1016/j.lanepe.2025.101272 |
| dc.subject.decs | enfermedades hepáticas |
| dc.subject.decs | /terapia |
| dc.subject.decs | política sanitaria |
| dc.subject.decs | salud urbana |
| dc.relation.publishversion | https://doi.org/10.1016/j.lanepe.2025.101272 |
| dc.type.version | info:eu-repo/semantics/publishedVersion |
| dc.audience | Professionals |
| dc.contributor.organismes | Institut Català de la Salut |
| dc.contributor.authoraffiliation | [Lazarus JV] Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain. Faculty of Medicine and Health Sciences, University of Barcelona, Barcelona, Spain. CUNY Graduate School of Public Health and Health Policy (CUNY SPH), New York, NY, USA. [Miralles-Sanchez JE, Agirre-Garrido L, Brachowicz N, Nicolàs A, Armenta A] Barcelona Institute for Global Health (ISGlobal), Barcelona, Spain. [Pericàs JM] Servei d’Hepatologia, Vall d’Hebron Hospital Universitari, Barcelona, Spain. Vall d’Hebron Institut de Recerca (VHIR), Barcelona, Spain. Universitat Autònoma de Barcelona, CIBERehd, Barcelona, Spain. Johns Hopkins University-Pompeu Fabra University Public Policy Center, Barcelona, Spain |
| dc.identifier.pmid | 40207291 |
| dc.identifier.wos | 001455597500001 |
| dc.rights.accessrights | info:eu-repo/semantics/openAccess |